Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Centre did injustice to Telangana in allocation of Bulk Drug parks: KT Rama Rao

Ruchika Sharma4 Sept 2022 2:00 PM IST

Hyderabad: Telangana IT and Industries Minister, KT Rama Rao on Friday alleged that the Centre made injustice to Telangana in the allocation of bulk...

IDRS Labs seeks DCGI emergency nod for plant based drug against long COVID

Ruchika Sharma4 Sept 2022 12:00 PM IST

A tripartite Memorandum of Agreement was signed among BARC, ACTREC-TMC and IDRS to develop Chlorophyllin against COVID-19 disease and other...

Moderna Omicron-targeting bivalent COVID-19 booster vaccine gets Canadian approval

Ruchika Sharma4 Sept 2022 10:00 AM IST

Cambridge: Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, has announced that Health Canada has...

47000 capsules of Sarten DSR seized from Pharma company in HP

Ruchika Sharma3 Sept 2022 4:45 PM IST

Shimla: A pharma firm in Himachal Pradesh has been under the scanner after an input regarding some notorious activities were reported to Himachal...

Pharma Firm Slapped Rs 15 Lakh for Infringing IPCAs ZERODOL Trademark

Covishield related death: Bombay HC issues notices to Serum Institute, DCGI Chief

Ruchika Sharma3 Sept 2022 3:56 PM IST

He has sought compensation of Rs 1000 crore for the alleged death of his daughter Dr Snehal Lunawat after taking the Covishield vaccine.

Reckitt Benckiser: Laxman Narasimhan steps down as CEO, Nicandro Durante appointed

Ruchika Sharma3 Sept 2022 2:00 PM IST

New Delhi: Reckitt Benckiser Group plc has announced that its CEO, Laxman Narasimhan will step down as Chief Executive Officer on September 30, 2022....

Lupin, Zydus Lifesciences recall products in US over manufacturing issues

Ruchika Sharma3 Sept 2022 12:03 PM IST

New Delhi: Home-grown drug makers Zydus Lifesciences and Lupin are recalling products in the US, the world's largest market for medicines, due to...

Boehringer Ingelheim gets USFDA nod for SPEVIGO to treat generalized pustular psoriasis flares

Ruchika Sharma3 Sept 2022 11:00 AM IST

Ridgefield: Boehringer Ingelheim has announced that the U.S. Food and Drug Administration (USFDA) has approved SPEVIGO, the first approved treatment...

Philips arm to pay over Rs 191 crore for alleged false claims for respiratory-related medical equipment

Ruchika Sharma3 Sept 2022 10:00 AM IST

A Philips spokesperson said its subsidiary agreed to settle the claim to avoid the required expense of litigating the allegations.

Sanofi gets USFDA nod for ASMD drug Xenpozyme

Ruchika Sharma2 Sept 2022 3:57 PM IST

ASMD, historically known as Niemann-Pick disease types A, A/B, and B, is an extremely rare, progressive genetic disease with significant morbidity and...

Department of Pharmaceuticals grants 'in-Principle' nod to 3 states to set up bulk drug parks

Ruchika Sharma2 Sept 2022 3:00 PM IST

Maximum assistance under the scheme for one Bulk Drug Park would be limited to Rs. 1000 crores.

Pfizer-BioNTech gets USFDA emergency use nod for Omicron BA.4/BA.5-Adapted Bivalent COVID vaccine booster for 12 years and older

Ruchika Sharma2 Sept 2022 2:00 PM IST

The Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok